Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.59 |
| ▸ | CA2 | P00918 | 7/20 | 0.59 |
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA9 | Q16790 | 5/20 | 0.59 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.47 |
| ▸ | SUCNR1 | Q9BXA5 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | ACACB | O00763 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1541945 | 0.91 | CA1 (0.64) | CA1CA2CA12CA9NAMPT | |
| SCHEMBL2328368 | 0.90 | CA1 (0.61) | CA1CA2CA12CA9ITGB3 | |
| SCHEMBL31108253 | 0.88 | CA1 (0.62) | CA1CA2CA12CA9GPR35 | |
| SCHEMBL23291262 | 0.88 | CA1 (0.55) | CA1CA2CA12CA9NAMPT | |
| SCHEMBL30048842 | 0.88 | CA2 (0.59) | CA1CA2CA12CA9NAMPT | |
| SCHEMBL910539 | 0.88 | CA1 (0.62) | CA1CA2CA12CA9ITGB3 | |
| SCHEMBL26964370 | 0.87 | CA1 (0.56) | CA1CA2CA12CA9NAMPT | |
| SCHEMBL19003451 | 0.87 | ACACB (0.61) | CA1CA2CA12CA9NAMPT | |
| SCHEMBL31108265 | 0.86 | CA1 (0.55) | CA1CA2CA12CA9ITGB3 | |
| SCHEMBL13886735 | 0.86 | NPC1 (0.57) | CA1CA2CA12CA9NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9562113-B2 | Labeled alginate conjugates for molecular imaging applications | BELLEROPHON BCM LLC (US) | 2017-02-07 | — | — | US | disclosed |
| US-20160115252-A1 | Labeled Alginate Conjugates For Molecular Imaging Applications | IKARIA DEVELOPMENT SUBSIDIARY ONE LLC | 2016-04-28 | — | — | US | disclosed |
| EP-2788334-B1 | LABELED ALGINATE CONJUGATES FOR MOLECULAR IMAGING APPLICATIONS | BELLEROPHON BCM LLC (US) | 2016-03-23 | — | — | EP | disclosed |
| US-9260399-B2 | Labeled alginate conjugates for molecular imaging applications | BELLEROPHON BCM LLC (US) | 2016-02-16 | — | — | US | disclosed |
| US-20150133645-A1 | Labeled Alginate Conjugates For Molecular Imaging Applications | IKARIA DEVELOPMENT SUBSIDIARY ONE LLC | 2015-05-14 | — | — | US | disclosed |
| US-8974766-B2 | Labeled alginate conjugates for molecular imaging applications | BELLEROPHON BCM LLC (US) | 2015-03-10 | — | — | US | disclosed |
| WO-2013086396-A1 | LABELED ALGINATE CONJUGATES FOR MOLECULAR IMAGING APPLICATIONS | IKARIA DEVELOPMENT SUBSIDIARY ONE LLC (US) | 2013-06-13 | — | — | WO | disclosed |
| US-20130149242-A1 | Labeled Alginate Conjugates for Molecular Imaging Applications | IKARIA DEVELOPMENT SUBSIDIARY ONE LLC (US) | 2013-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160115252-A1 | Labeled Alginate Conjugates For Molecular Imaging Applications | ALG1, ALG8, ALG3 | CA1 238/4885CA2 204/4885CA12 201/4885 |
| US-20150133645-A1 | Labeled Alginate Conjugates For Molecular Imaging Applications | ALG1, ALG8, ALG3 | CA1 238/4885CA2 204/4885CA12 201/4885 |
| US-20130149242-A1 | Labeled Alginate Conjugates for Molecular Imaging Applications | ALG1, ALG8, ALG3 | CA1 238/4885CA2 204/4885CA12 201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.